Scientists are increasingly investigating retatrutide, a promising treatment created by Eli Lilly, as a possible step in body loss . Distinct from many previous approaches, retatrutide is a dual -action compound targeting simultaneously GLP-1 and GIP, hormones that affect satiety and blood sugar… Read More